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Radiology in Focus
Optimum imaging for sinonasal malignancy
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Abstract
A combination of computed tomography (CT) and magnetic resonance imaging (MRI) is now established as the
optimum assessment of sinonasal malignancy. CT and MRI are of particular value in assessing the skull base,
orbit and pteryo-palatine and infratemporal fossae. Although MRI offers better differentiation of tumour from
surrounding tissue and ￿uid, coronal CT is still required for the demonstration of bone erosion particularly in
the region of the cribriform plate. Thus the extent of local tumour spread may be determined with a degree of
accuracy in excess of 98 per cent. However, the ￿nal determinant of penetration of the dura and orbital
periosteum requires per-operative frozen section assessment. A knowledge of the tissue characteristics and site
of origin can be of value in distinguishing some of the commoner sinonasal malignancies such as squamous cell
carcinoma, adenocarcinoma, adenoid cystic carcinoma, olfactory neuroblastoma and chondrosarcoma. Imaging,
particularly MRI also plays an important role in the post-therapeutic follow-up of patients, indicating areas of
residual or recurrent disease, de￿ning suspicious areas for biopsy. Post-operative surveillance is best achieved
with three planar T1-weighted MRI, with, and without, gadolinium and axial T2-weighted sequences. The
subtraction of the T1 pre- and post gadolinium T1 sequences can be of particular value in delineating
recurrence.
Key words: Magnetic resonance imaging; Tomography, X-ray computed; Paranasal sinus neoplasms
Introduction
In general, imaging has a threefold part to play in the
management of sinonasal malignancy; ￿rstly, at an early
stage, the tumour may be inaccessible to clinical methods
of examination and the initial diagnosis must be made by
the radiologist and secondly, it is the best method of
establishing the extent of the disease prior to treatment. In
this respect CT and gadolinium-enhanced magnetic reso-
nance (GdMR) are invaluable.
1–5 These techniques will
show the best area for biopsy of the tumour, the presence
of bone destruction, and the precise outlines of the mass
both within the sinuses and in adjacent structures. Thirdly,
imaging is of increasing importance in the post-operative
surveillance of malignant sinus disease.
Materials and method
This review is based on an analysis of the imaging of 246
histologically proven malignant sinonasal tumours col-
lected over a 20-year period, since the introduction of
routine bi-planar head and neck CT in 1978, from a cohort
of 515 malignant tumours.
Plain X-ray changes
The striking feature of plain X-ray changes is their
unilateral nature with occlusion of one side of the nasal
cavity and totally opaque sinuses on the same side. This is
the result of a combination of direct tumour invasion and
retained secretion. Typically, the nasal septum is bowed
toward the normal side by the tumour mass and the contra-
lateral sinuses are clear. The changes are most character-
istic of squamous cell carcinoma, the commonest sino-nasal
malignancy. (Figure 1)
Fig. 1
Plain sinus X-ray (occipito-mental view) showing unilateral
opacification of the maxillary sinus with occlusion of the
adjacent nasal cavity and bowing of nasal septum.
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Malignant sinus tumours are now optimally assessed by a
combination of CT and GdMR; CT to show sites of bone
destruction and GdMR to show soft tissue spread. (Table
I). The CT protocol differs from that used for in￿amma-
tory disease and should be utilized whenever neoplasia is
suspected. MRI allows soft tissue differentiation between
tumour, in￿ammation, retention of mucus and ￿brosis as
con￿rmed by studies comparing histological ￿ndings at
cranio-facial resection with pre-operative imaging. Using
this protocol a correct correlation between CT and
histology was found in 85.2 per cent of areas examined.
The correlation of MRI with histological ￿ndings improves
this ￿gure to 94.1 per cent and the addition of gadolinium
DTPA increase the correlation to 98.4 per cent.
5 However,
the microscopic relationship of the tumour to orbital
periosteum and dura cannot be resolved by imaging alone
and must rely upon frozen section at the time of surgery.
1
The three plane multi-slice facility, using a head coil, gives
total coverage of the head and neck so that both the
primary tumour and any direct or metastatic cervical
involvement can be recognized Although the latter is a
relatively infrequent accompaniment to sino-nasal malig-
nancy occurring in fewer than 10 per cent of cases.
The combination of CT and MRI are of particular value
in assessing several important anatomical sites:
(1) Skull base. Signi￿cant extension of disease through
the cribriform plate into the anterior cranial fossa is best
demonstrated by GdMR although early erosion is best
seen on coronal CT. Tumours in this area can be shown on
MRI by T2-weighted sequences which discriminate well
between tumour and in￿ammation extra-cranially. How-
ever, T2 images have the disadvantage of poor discrimina-
tion between tumour and cerebral oedema. On the other
hand the addition of gadolinium-DTPA to T1-weighted
sequences will make this distinction clear and show the
exact limits of the tumour; the oedema is not affected by
the contrast medium. Similarly in the sinuses themselves,
retained secretion is not affected by the gadolinium so that
there is a clear distinction between tumour and ￿uid
(Figure 2). Dural thickening and enhancement can be
more dif￿cult to interpret as this can occur as a reactive
phenomenon adjacent to intracranial tumour extension but
can also follow surgery or radiotherapy in the absence of
residual or recurrent tumour.
(2) Orbit. Extension of disease into the orbit can be
shown by either CT or MRI.
6,7 Two varieties of orbital
invasion can be demonstrated.
i(i) The more common type of invasion is seen in both
benign and malignant sinus tumours. In this the orbital
contents are displaced laterally without direct invasion,
the peri-orbita acting as a barrier and resisting tumour
in￿ltration.
(ii) The second, less common type of orbital invasion is a
direct in￿ltration of the retrobulbar structures by
tumour so that the normal anatomical landmarks are
obliterated. This represents a later stage of orbital
tumour spread. In fact pre-contrast T1 sequences offer
good demonstration of the tumour/fat interface.
Gadolinium enhancement is helpful in the MR
demonstration of orbital invasion but the contrast
medium may enhance tumour signal to the same
intensity as that of orbital fat, rendering the lesion less
conspicuous. Fat suppression sequences must be
performed to overcome this problem. The quality of
fat suppression does vary from scanner to scanner and
subtraction images can be useful. The non-enhancing
of adipose tissue ensures almost total subtraction of the
fat signal so that the extent of tumour within the orbit
is optimally shown. (Figure 3a, b).
(3) Pterygo-palatine and intratemporal fossae. The
signi￿cance of these areas is related to the con￿uence
within them of a number of vascular and lymphatic
channels connecting the face and the cranium; once the
pterygo-palatine fossa is invaded, these allow easy tumour
access to the middle cranial fossa, orbit, nose, nasopharynx
and palate, indicating that the tumour is likely to be
beyond the limits of complete resectability. CT has been
the best method of demonstrating early pterygo-palatine
fossa involvement, and was regarded as superior to
magnetic resonance, largely because of the combination
of soft tissue and bone imaging available. However, MRI is
now as good as, if not better than, CT especially when
there is more extensive invasion of the infratemporal fossa.
TABLE I




(one plane with and without contrast enhancement)
Filters and reconstruction algorithms should be suitable for
both soft tissue and bone window settings
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T1-weighted gadolinium-enhanced MRI showing the differ-
entiation between tumour, fluid and mucosal thickening in a
case of malignant schwannoma.
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Regular post-operative surveillance by MRI is now routine
following major surgery for sinus malignancy, whether
there is clinical suspicion of recurrence or not. It is
important to show early recurrence so that treatment by
revision surgery and radiotherapy may be successful in
preventing further extension or metastases. The frequency
of the investigation and duration of the follow-up depends
on the tumour type and patient availability but is generally
performed every four to six months during the ￿rst two
years and thereafter on a nine to 12 month basis.
Many tumour recurrences are diagnosed by clinical
inspection particularly by endoscopy, but imaging is
essential to visualize those areas that are inaccessible
clinically. Again the cavity and extra-cranial areas can be
shown well on T2-weighted scans but GdMR facilitates the
demonstration of intracranial tumour recurrence after
cranio-facial resection (Figures 4a and b) (Table I). In
the subtraction process the magnetic resonance signal is
removed from the ￿nal image so that the densities
recorded are dependent only upon the enhancement of
the tissue concerned, whether normal or pathological.
8,9
Subtraction is most advantageous in situations where the
anatomy is complex, as at the skull base, or in tumour
recurrence where normal structures are distorted by
previous surgery.
Tissue characteristics. The commoner histological vari-
eties of malignant sino-nasal tumour may show some
distinguishing features on CT and MR.
Most squamous cell carcinomas arise in the nose or
maxillary antrum, but when ￿rst seen the tumours usually
involve the nasal cavity, antrum and ethmoids. They tend
to spread posteriorly invading the pterygo-palatine fossa at
an early stage: in the series under review 70 per cent
showed CT evidence of this invasion at initial examination,
which undoubtedly contributes to the poor prognosis of
these tumours (32 per cent ￿ve-year survival) (Figure 5a,
b).
10
Adenocarcinoma may present a similar distribution, but
a greater number (63 per cent) show a different location,
being principally naso-ethmoidal, occupying the upper part
of the nasal cavity and adjacent ethmoid cells. From this
point of origin adenocarcinoma can gain early access to the
cribriform plate area and the anterior cranial fossa, and the
prognosis following cranio-facial surgery is directly related
to the presence or absence of anterior fossa invasion which
may be seen on the pre-operative scans (Figure 6).
10
Extension readily occurs anteriorly into the glabellar
region and posteriorly into the sphenoethmoidal recess
and nasopharynx – areas to which special attention must
be paid on examining the imaging. Adenocarcinoma also,
not infrequently, crossed the midline to the opposite
ethmoid complex.
Adenoid cystic carcinoma is a malignant tumour derived
from salivary-type seromucinous glands in the nose and
paranasal sinuses. The majority of these tumours originate
in the lower part of the nasal cavity and may involve both
the hard and soft palate at an early stage. Some may
present as a bulk tumour occupying an antro-ethmoidal
location but many do not show as a large mass but tend to
in￿ltrate soft tissue: they advance along tissue planes by
Fig. 3(b)
Subtraction GdMR in the same patient showing tumour
enhancement within the orbit and no signal from the frontal
sinus, showing that the opacification on CT was fluid.
Fig. 3(a)
Coronal CT scan showing a small cell carcinoma of the upper
medial quadrant of the orbit with opacification of the adjacent
frontal sinus.
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Subtraction GdMR showing normal post-operative cranio-
facial cavity with high signal from normal nasal mucosa.
Fig. 4(b)
Subtraction GdMR showing post-operative craniofacial cavity
with recurrent olfactory neuroblastoma in the maxillary sinus,
adjacent to orbit.
Fig. 5(a)
Axial CT scan showing squamous cell carcinoma of the
maxillary sinus with expansion and erosion of the bone.
Tumour extension is seen into the pterygoid region.
Fig. 5(b)
T1-weighted MR of same case.
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the primary lesion or embolic. MRI can be helpful in
demonstrating this.
In certain cases the tumour may represent a secondary
deposit in the sinuses e.g. clear cell renal carcinoma when
further imaging of the abdomen may be appropriate.
Similarly some types of sinonasal tumour have a propen-
sity for metastatic spread e.g. adenoid cystic carcinoma
giving secondary deposits in the lungs and further imaging
may be required as part of the pre-operative evaluation.
Olfactory neuroblastoma most usually arises from the
olfactory epithelium in the nasal roof (although other
locations can be found), and presents in the sub-cribriform
plate area on CT and MRI. Erosion of the cribriform plate
is an early feature and is best demonstrated by CT (Figure
7). These tumours are, on average, more vascular than the
carcinomata although the degree of enhancement on MR
and CT may be similar. Histological analysis of craniofacial
specimens has shown microscopic involvement of the
olfactory bulbs and tract early in the disease.
11 As with
adenocarcinoma, the prognosis is signi￿cantly worsened
when the tumour is shown macroscopically to invade the
anterior fossa or orbit on pre-operative imaging.
The commonest malignant sinonasal tumour of con-
nective tissue origin is chondrosarcoma. This tumour has a
high long-term survival rate but a high rate of recurrence
requiring repeated cranio-facial resection.
10 On CT they
present as a lobulated mass expanding and destroying
bone and typically contain areas of nodular or plaque-like
calci￿cation. The diagnostic feature on MRI is a differ-
ential enhancement of the mass of T1-weighted post-
gadolinium sequences. The contrast enhancement is seen
at the periphery of the tumour and the central chondro-
matous core fails to enhance. These changes are depen-
dent on the vascularity of the tissues concerned and
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Fig. 7
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Fig. 8
Coronal CT showing chondrosarcoma of the perpendicular
plate of ethmoid, vomer and face of sphenoid with
characteristic calcification.
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